Specific ECM Degradation Potentiates the Antitumor Activity of CAR-T Cells in Solid Tumors

Investigators engineered chimeric antigen receptor (CAR)-T cells with synthetic Notch receptors, which induced local tumor-specific secretion of ECM-degrading enzymes at the tumor site.